A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.
January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
The Hong Kong stock market has finished lower in two of three trading days since the end of the three-day winning streak in which it ...
The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...
The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub.
Chinese CRDMOs are expected to see a temporary reprieve this year following the delay of the Biosecure Act in 2024, said UOB Kay Hian.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback